VRG Technologies, Inc.


 Home Up Products Patents Investing Press Releases Contacts

  Cancer Treatment


Vector Research - Global Technologies.


Cancer is a disease that is likely to affect most Americans in their lifetime. In the U.S. men have a 1 in 2 chance and women a 1 in 3 chance of developing cancer (or dying from it) in their lifetime. Furthermore, cancer is a disease of ageing and the over 50 population in the U.S. is growing tremendously. With this in mind, it is easy to see why cancer diagnostic and treatment products and technologies represent billion dollar industries. A number of important technological advances, such as the heightened impact of molecular biology, have affected these industries.

According to a soon-to-be-released BUSINESS COMMUNICATIONS CO., INC. study RC- 047U Cancer Treatment and Diagnostic Products, the value of cancer diagnostic and treatment products is estimated at $14.62 billion, $15.97 billion and $17.49 billion in 1996, 1997 and 1998 respectively. BCC forecasts that by 2003 the value will increase to $25.04 billion, representing an AAGR of 7.4%, over the period 1998-2003.

The total value for cancer treatment was around $9.32 billion in 1998. This segment is forecasted to reach $15.35 billion in 2003, representing an AAGR of 10.5%. The cancer treatment segment consists of surgical and radiation therapy products as well as pharmaceuticals.

BCC predicts that the fastest growing segments of this market will be brachytherapy radioisotopes; radiopharmaceuticals; biological drugs (especially monoclonal antibody-based products); and hormone, anti-hormone and anti-tubule chemical drugs.

The value for cancer diagnostics stood at $8.16 billion in 1998 and is expected to be $9.69 billion in 2003, representing an AAGR of 3.5%. The cancer diagnostics sector consists of imaging devices, imaging and detection reagents and laboratory tests (including biopsies and in- vitro tests).

BCC predicts that the fastest growing sectors of this market will be contrast media for ultrasound and MRI, and in-vitro diagnostic tests.

($ Millions)

  1998 2003 AAGR %
1998- 2003
Treatment 9,323 15,353 10.5
Diagnosis 8,163 9,689 3.5
Total 17,486 25,042 7.4

*Note: All calculations in the table are based on product sales except for the value of laboratory tests in the Diagnosis section. The Laboratory Test subsection includes both in-vitro tests as well as the total cost (including labor and reagents) to perform tissue biopsies, since they are surgical procedures.

Source: Business Communications Company, Inc.

RC-047U Cancer Treatment and Diagnostic Products

PUBLISHED: February 1999

Data and analysis provided courtesy of BUSINESS COMMUNICATIONS COMPANY, INC., 25 Van Zant Street, Norwalk, CT 06855,  Telephone: (203) 853-4266; ext. 309,  Email: publisher@bccresearch.com

Back Home Up Next 


VRG Technologies, Inc.

Last Modified : 12/10/01 07:09 PM

Copyright 2001